US FDA Tackles HDE 'Probable Benefits' Question In Draft Guidance
Executive Summary
In accordance with the 21st Century Cures Act, FDA has published a draft guidance on how it will assess devices intended for orphan diseases under the humanitarian device exemption pathway. A key part of the guidance attempts to address the agencies thinking on what is considered probable benefit.
You may also be interested in...
Final Guidance Clarifies HDE Process, ‘Probable Benefit’
The US FDA has finalized a guidance document on the humanitarian device exemption process. The revision brings the document in line with requirements of the 21st Century Cures Act.
Final Guidance Encourages Use Of Patient Preference In Device Applications
US FDA released a final guidance aimed at helping sponsors and other stakeholders interested in using patient-preference information to make their case for a device application. The agency has decided to keep its labeling recommendation in the final guidance despite industry objections.
Massive Family Dollar Rat Infestation Leads To Multi-State Recall
The US FDA found more than 2,000 rats at an Arkansas Family Dollar distribution center, leadingto a six-state recall for products including feminine hygiene products, contact lens cleaners and face masks.